Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2005
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652775A Peptide deformylase inhibitors
08/10/2005CN1651429A One step preparation method of paluxitin hydrochloride A crystal type crystal molecule assembly
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214087C Novel red fluorescent material and organic electroluminescent device containing same
08/10/2005CN1214017C 四唑衍生物 Tetrazole derivatives
08/10/2005CN1213658C Picolinamide derivatives and pest controllers containing same as active ingredient
08/09/2005US6927295 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
08/09/2005US6927294 Nitrogen-containing heterocycles
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927214 Non-peptide GLP-1 agonists
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2249330C Method of treating heart failure with endothelin antagonists
08/09/2005CA2231700C Prodrugs of aspartyl protease inhibitors
08/04/2005WO2005070923A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
08/04/2005WO2005070900A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
08/04/2005WO2005070893A2 Azadecalin glucocorticoid receptor modulators
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070889A1 Herbicidal amides
08/04/2005WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
08/04/2005WO2005070430A1 Quinoline derivatives and use thereof as mycobacterial inhibitors
08/04/2005WO2005069981A2 Method of preparation of benzofuran-2-carboxylic acid {(s)-3-methyl-1-[(4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide
08/04/2005WO2005058865A3 Assay for entactogens
08/04/2005WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005037199A3 Pyrazole derivatives as cannabinoid receptor modulators
08/04/2005WO2005019201A3 Process for the preparation of 4-amino-3-quinolinecarbonitriles
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
08/04/2005US20050171187 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate
08/04/2005US20050171185 Indole derivatives
08/04/2005US20050171184 Resolution with acid; salt formation, cyclization
08/04/2005US20050171175 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
08/04/2005US20050171172 platelet derived growth factor receptor; anticarcinogenic; leukemia; specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171171 colony-stimulating factor receptor (c- FMS)-like tyrosine kinase 3; anticarcinogenic; leukemia;specific kinase inhibitors; accurate targeting with limited inhibition of other pathways; reduced toxicity
08/04/2005US20050171164 5-substituted-alkylaminopyrazole derivatives as pesticides
08/04/2005US20050171160 Doxepin analogs and methods of use thereof
08/04/2005US20050171156 Prodrugs of potassium channel inhibitors
08/04/2005US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
08/04/2005US20050171146 Non-peptidic BRS-3 agonists
08/04/2005US20050171136 Modulators of the glucocorticoid receptor and method
08/04/2005US20050171132 Diaminopyrimidine derivatives as selective growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171131 Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists
08/04/2005US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors
08/04/2005US20050171098 MCH antagonists and their use in the treatment of obesity
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050170363 For conjugation with biomolecules, drugs, and toxins
08/04/2005US20050169837 Coumarines useful as biomarkers
08/04/2005CA2553966A1 Vanilloid receptor ligands and their use in treatments
08/04/2005CA2553513A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors
08/04/2005CA2552419A1 Azadecalin glucocorticoid receptor modulators
08/03/2005EP1559713A1 Chromene compound
08/03/2005EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same
08/03/2005EP1559374A1 Cyanine dyes
08/03/2005EP1558745A1 Mutagenesis methods using ribavirin and/or rna replicases
08/03/2005EP1558608A1 Oxindole substituted piperazine derivatives
08/03/2005EP1558606A2 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
08/03/2005EP1558605A2 Process for making spirolactone compounds
08/03/2005EP1558604A1 Quaternary ammonium compounds and their use as antimuscarinic agents
08/03/2005EP1558603A2 Oxyge-containing heterocyclic fused naphthopyrans
08/03/2005EP1558598A1 Triazole compounds for the treatment of dysmenorrhoea
08/03/2005EP1558591A2 Modulation of anxiety through blockade of anandamide hydrolysis
08/03/2005EP1558583A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists
08/03/2005EP1558582A1 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
08/03/2005EP1558581A2 Triazolone and triazolethione derivatives
08/03/2005EP1558579A1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
08/03/2005EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds
08/03/2005EP1558341A2 Transcription factor modulating compounds and methods of use thereof
08/03/2005EP1558260A2 Quinazolinone compounds as calcilytics
08/03/2005EP1558246A1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/03/2005EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP1087948B1 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005EP1016661B1 2,6-dichloro-4-pyridinemethanol derivatives as agricultural chemicals
08/03/2005CN1649865A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649859A Substituted phenylacetamides and their use as glucokinase activators
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649844A Isoquinoline derivatives
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649840A Non-peptidic BRS-3 agonists
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649594A Process for the preparation of benazepril hydrochloride
08/03/2005CN1649590A Therapeutic agent comprising lafutidine
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 694